Low-dose intravenous pamidronate treatment in osteogenesis imperfecta
Articles > Article · 2006
Authors: Ruhsar Damla GÖKŞEN, Mahmut ÇOKER, Şükran DARCAN, Timur KÖSE, Serdar KARA
TURKISH JOURNAL OF PEDIATRICS, Journal Indexed in SCI Expanded, International, 2006, vol 48, pp 124-129
Summary
Different therapy models have been tried in order to decrease bone resorption in osteogenesis imperfecta. Bisphosphonates are a group of drugs that mainly suppress osteoclast-mediated bone resorption, thus reducing bone turnover. We assessed the effects of low-dose bisphosphonate treatment in children with osteogenesis imperfecta.